Literature DB >> 32843465

Double jeopardy: a patient's tale of two concurrent hypercalcaemic syndromes.

Aditi Sharma1, Fatima Bahowairath2, Chukwuma Uduku3, Julia E Ostberg2.   

Abstract

Primary hyperparathyroidism (PHPT) is the most common cause of parathyroid hormone (PTH) dependent hypercalcaemia, however there are few reported cases of its co-occurrence in patients with familial hypocalciuric hypercalcaemia (FHH). This case highlights the challenges in managing a rare case of dual pathology. A 49-year-old Caucasian woman with symptoms of hypercalcaemia presented with an adjusted serum calcium of 2.77 mmol/L and PTH of 11.5 pmol/L. Neck ultrasound and sestamibi scan were concordant with a left lower parathyroid adenoma, and a preoperative dual-energy X-ray absorptiometry scan confirmed osteopenia. Parathyroidectomy resulted in a PTH reduction from 11.5 pmol/L to 2.7 pmol/L. Interestingly, her lowest pre-operative adjusted serum calcium of 2.67 mmol/L remained unchanged 14 months post-parathyroidectomy. Twenty-four hours urine calcium:creatinine clearance ratio performed postoperatively was low and sequencing analysis of the calcium-sensing receptor gene confirmed the coexistence of FHH. Although surgery is not indicated in FHH, parathyroidectomy may help reduce hypercalcaemia and its associated complications if there is coexistent PHPT. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  calcium and bone; head and neck surgery

Mesh:

Year:  2020        PMID: 32843465      PMCID: PMC7449346          DOI: 10.1136/bcr-2020-237036

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

1.  Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug.

Authors:  Gerolamo Bianchi; Andrea Giusti; Giulio Pioli; Antonella Barone; Ernesto Palummeri; Giuseppe Girasole
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

Review 2.  Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.

Authors:  Leslie S Eldeiry; Daniel T Ruan; Edward M Brown; Jason L Gaglia; Jeffrey R Garber
Journal:  Endocr Pract       Date:  2012 May-Jun       Impact factor: 3.443

3.  Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor.

Authors:  T Carling; E Szabo; M Bai; P Ridefelt; G Westin; P Gustavsson; S Trivedi; P Hellman; E M Brown; N Dahl; J Rastad
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

4.  Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications.

Authors:  D S Rao; M Honasoge; G W Divine; E R Phillips; M W Lee; M R Ansari; G B Talpos; A M Parfitt
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

5.  Parathyroidectomy in familial hypercalcemia with clinical characteristics of primary hyperparathyroidism and familial hypocalciuric hypercalcemia.

Authors:  Eva Szabo; Per Hellman; Ewa Lundgren; Tobias Carling; Jonas Rastad
Journal:  Surgery       Date:  2002-03       Impact factor: 3.982

6.  Parathyroid adenoma in a patient with familial hypocalciuric hypercalcaemia.

Authors:  Hannah Elizabeth Forde; Arnold D Hill; Diarmuid Smith
Journal:  BMJ Case Rep       Date:  2014-10-15

7.  Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.

Authors:  Stephen J Marx
Journal:  J Bone Miner Res       Date:  2017-12-11       Impact factor: 6.741

8.  Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity.

Authors:  H Heath; C E Jackson; B Otterud; M F Leppert
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

9.  Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M R Pollak; E M Brown; Y H Chou; S C Hebert; S J Marx; B Steinmann; T Levi; C E Seidman; J G Seidman
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

10.  Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13.

Authors:  S E Lloyd; A A Pannett; P H Dixon; M P Whyte; R V Thakker
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.